health insurance

Debt financing Kookmin Bank raises $700 mn in forex bonds amid strong demand

Kookmin Bank, a unit of KB Financial Group, raised $700 million in foreign exchange bonds on Tuesday, signaling a recovery in investor sentiment tow...

Mergers & Acquisitions CJ CheilJedang scraps sale of Brazilian unit CJ Selecta to Bunge

CJ CheilJedang Corp., South Korea’s largest food company, has cancelled the sale of a 66% stake in Brazilian soybean crusher CJ Selecta S.A. a...

Mergers & Acquisitions Kyobo Life poised to buy Japan’s SBI Group-owned savings bank

Kyobo Life Insurance Co. is in the final stages of negotiation with Japanese financial group SBI Holdings Inc. to buy about a 50% stake in SBI Savin...

Corporate strategy Samsung seeks tech alliance with top US universities for robotics, AI, 6G

In an ambitious bid to shape the future of technology, Samsung Electronics Co. is launching a sweeping initiative to collaborate with elite North Am...

Mergers & Acquisitions DB Insurance becomes Daol Investment’s No.2 shareholder

DB Insurance Co., a leading South Korean non-life insurance company, has become Daol Investment & Securities Co.'s second-largest shareholder af...

Retail Koreans cut spending in March, except on health, education

South Korean consumers exhibited recessionary spending behavior in March, cutting expenditures across nearly all sectors, except healthcare and educ...

Retail Koreans cut spending in March, except on health, education

South Korean consumers exhibited recessionary spending behavior in March, cutting expenditures across nearly all sectors, except healthcare and educ...

Leadership & Management Kakao founder Kim to resign as control tower chair

Kakao Corp. founder Kim Beom-soo, also known as Brian Kim, will step down as chairman of the South Korean tech giant’s top decision-making bod...

Mergers & Acquisitions Meritz drops bid for troubled MG Non-Life Insurance; Liquidation looms

Meritz Financial Group Inc., South Korea’s second-most valuable financial holding firm, has dropped its bid to acquire financial distressed MG...

Korean Investors Samsung to invest $10 million in US-based C2N Diagnostics

Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s d...

Private equity Affinity, GIC sell out of Kyobo Life; Chairman Shin seeks holding firm, M&A

Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...

Upcoming IPOs Seoul Guarantee Insurance to raise $124 million from IPO

Seoul Guarantee Insurance Co. (SGI) will raise 181.5 billion won ($124.2 million) through an initial public offering later this month in its second ...

IPOs Korean firms cut IPO prices, volumes amid bearish sentiment

South Korean companies are relaunching attempts to go public with lower valuations and fewer shares amid continued sour investor sentiment.CK Soluti...

Upcoming IPOs Seoul Guarantee Insurance sharply cuts IPO valuation

Seoul Guarantee Insurance Co. (SGI) has slashed its target valuation by about 40% in a renewed attempt to go public on the South Korean stock exchan...

Bio & Pharma Celltrion gets approval of Omlyclo in Canada

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

Mergers & Acquisitions Hanwha Life acquires US securities firm Velocity

South Korea's Hanwha Life Insurance said on Wednesday it signed a stock purchase agreement (SPA) to acquire a 75% stake in Velocity Clearing LLC, ...

Bio & Pharma Macrogen's GenTok to feature on Samsung Health app

South Korea's biotech company Macrogen, Inc. signed a supply agreement to integrate its genome analysis platform, GenTok, into the Samsung Health ap...

Tech, Media & Telecom SK C&C unveils digital SHE consulting service

South Korea's SK C&C said on Thursday that it launched its Digital SHE Consulting Service,  the artificial intelligence (AI) platform tha...

Bio & Pharma Volpara to supply breast cancer SW to US Defense Health Agency

Lunit, a South Korean cancer diagnostics AI company, said on Monday its US subsidiary Volpara Health secured a 10 billion won ($7.5 million) contr...

Bio & Pharma Celltrion's Zymfentra gets 90% distribution channel in US

South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...

IPOs Korea’s LG CNS, DN Solutions seek billions of dollars via Jan IPOs

LG CNS Co., DN Solutions Co. and other South Korean companies aim to raise billions of dollars through domestic initial public offerings (IPOs) in J...

ASK 2024 Korean pension funds to up private equity exposure in 2025

South Korea's major pension and savings funds see no drastic reshuffle to their portfolios tilted to private debts next year. But they are looking t...

Insurance DB Insurance outshines domestic rivals in global business

DB Insurance Co. raked in the biggest profits from overseas operations among South Korean insurance companies in the first half of this year, leadin...

Companies Samsung develops health software development kit

Samsung Electronics Co. on Thursday introduced the Samsung Health Software Development Kit (SDK) Suite, aimed at helping developers and researchers ...

Food & Beverage Hanwha Galleria acquires beverage manufacturer Pure Plus

South Korea's Hanwha Galleria Corp. said on Monday its acquisition of domestic beverage manufacturer Pure Plus.Pure Plus has focused on non-alcoholi...

Food & Beverage Lotte Home Shopping, Asahi to cooperate on health functional food biz

South Korea's Lotte Home Shopping signed an exclusive agreement with Japan's Asahi Group Foods to supply and sell health functional food ingredients...

Bio & Pharma Volpara to supply cancer diagnostics SW to Intermountain Health

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software deve...

Corporate strategy SK seeks sale of specialty gas unit for around $3 bn

SK Group, the second-largest conglomerate in South Korea, is considering selling global leading specialty gas producer SK Specialty Co. for around 4...

Bio & Pharma Celltrion's Zymfentra joins US insurance-covered drug lists

South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...

Bio & Pharma Celltrion gets approval of Steqeyma in Canada

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...